Comparison of growth hormone responses to human pancreatic growth hormone releasing factor and other pharmacological stimuli in acromegalic patients. 1984

T Karashima, and K Sekiya, and S Ikuyama, and K Kato, and H Ibayashi

Synthetic human pancreatic growth hormone releasing factor (pGRF) was administrated intravenously to 14 acromegalic patients, and the response of plasma GH to pGRF was compared with that to TRH, GnRH or other GH-stimulating agents in these patients. Three patients hyperresponded (more than 8 times), 4 patients responded (2-4 times), 4 patients hyporesponded (1.5-2.0 times) and 3 patients did not respond at all. There was no correlation between the responses to TRH and pGRF, however, an intimate relationship was observed between responses to pGRF and GnRH in the patients who hyperresponded to pGRF. A patient not responding to pGRF showed a marked response to insulin or clonidine and another patient not responding to insulin or clonidine did respond to pGRF. Similarly, some patients not responding to FK 33-824, a met-enkephalin analog, or arginine did respond to pGRF.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010187 Pancreatic Hormones Peptide hormones secreted into the blood by cells in the ISLETS OF LANGERHANS of the pancreas. The alpha cells secrete glucagon; the beta cells secrete insulin; the delta cells secrete somatostatin; and the PP cells secrete pancreatic polypeptide. Hormones, Pancreatic
D010906 Pituitary Hormone-Releasing Hormones Peptides, natural or synthetic, that stimulate the release of PITUITARY HORMONES. They were first isolated from the extracts of the HYPOTHALAMUS; MEDIAN EMINENCE; PITUITARY STALK; and NEUROHYPOPHYSIS. In addition, some hypophysiotropic hormones control pituitary cell differentiation, cell proliferation, and hormone synthesis. Some can act on more than one pituitary hormone. Hormones, Pituitary Hormone Releasing,Hypophysiotropic Hormones,Hypothalamic Hypophysiotropic Hormone,Hypothalamic Releasing Factor,Hypothalamic Releasing Hormone,Hypothalamic Releasing Hormones,Hormone, Hypothalamic Hypophysiotropic,Hormones, Hypophysiotropic,Hypophysiotropic Hormone, Hypothalamic,Pituitary Hormone Releasing Hormones,Releasing Hormone, Hypothalamic
D003000 Clonidine An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION. Catapres,Catapresan,Catapressan,Chlophazolin,Clofelin,Clofenil,Clonidine Dihydrochloride,Clonidine Hydrochloride,Clonidine Monohydrobromide,Clonidine Monohydrochloride,Clopheline,Dixarit,Gemiton,Hemiton,Isoglaucon,Klofelin,Klofenil,M-5041T,ST-155,Dihydrochloride, Clonidine,Hydrochloride, Clonidine,M 5041T,M5041T,Monohydrobromide, Clonidine,Monohydrochloride, Clonidine,ST 155,ST155
D005260 Female Females
D005405 D-Ala(2),MePhe(4),Met(0)-ol-enkephalin A stable synthetic analog of methionine enkephalin (ENKEPHALIN, METHIONINE). Actions are similar to those of methionine enkephalin. Its effects can be reversed by narcotic antagonists such as naloxone. DAMME,FK 33-824,FK-33-824,FK-33824,Tyr-Ala-Gly-MePhe-Met-OH,FK 33 824,FK 33824,FK33824,Tyr Ala Gly MePhe Met OH
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000172 Acromegaly A condition caused by prolonged exposure to excessive HUMAN GROWTH HORMONE in adults. It is characterized by bony enlargement of the FACE; lower jaw (PROGNATHISM); hands; FEET; HEAD; and THORAX. The most common etiology is a GROWTH HORMONE-SECRETING PITUITARY ADENOMA. (From Joynt, Clinical Neurology, 1992, Ch36, pp79-80) Inappropriate Growth Hormone Secretion Syndrome (Acromegaly),Somatotropin Hypersecretion Syndrome (Acromegaly),Inappropriate GH Secretion Syndrome (Acromegaly),Hypersecretion Syndrome, Somatotropin (Acromegaly),Hypersecretion Syndromes, Somatotropin (Acromegaly),Somatotropin Hypersecretion Syndromes (Acromegaly),Syndrome, Somatotropin Hypersecretion (Acromegaly),Syndromes, Somatotropin Hypersecretion (Acromegaly)

Related Publications

T Karashima, and K Sekiya, and S Ikuyama, and K Kato, and H Ibayashi
January 1984, The Journal of clinical endocrinology and metabolism,
T Karashima, and K Sekiya, and S Ikuyama, and K Kato, and H Ibayashi
January 1986, Sheng li ke xue jin zhan [Progress in physiology],
T Karashima, and K Sekiya, and S Ikuyama, and K Kato, and H Ibayashi
February 1996, The Journal of clinical investigation,
T Karashima, and K Sekiya, and S Ikuyama, and K Kato, and H Ibayashi
February 1984, Endocrinologia japonica,
T Karashima, and K Sekiya, and S Ikuyama, and K Kato, and H Ibayashi
June 1984, Journal of endocrinological investigation,
T Karashima, and K Sekiya, and S Ikuyama, and K Kato, and H Ibayashi
January 1985, Biology of the neonate,
T Karashima, and K Sekiya, and S Ikuyama, and K Kato, and H Ibayashi
July 1984, The Journal of clinical investigation,
T Karashima, and K Sekiya, and S Ikuyama, and K Kato, and H Ibayashi
June 1983, British medical journal (Clinical research ed.),
T Karashima, and K Sekiya, and S Ikuyama, and K Kato, and H Ibayashi
May 2001, Journal of endocrinological investigation,
T Karashima, and K Sekiya, and S Ikuyama, and K Kato, and H Ibayashi
August 2000, European journal of endocrinology,
Copied contents to your clipboard!